N.N. Blokhin Russian Cancer Research Center / Российский онкологический научный центр им. Н. Н. Блохина

Research facility


Location: Moscow / Moskau, Russian Federation (RU) RU

ISNI: -

ROR: https://ror.org/00ab9fg88

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Evaluation of Prognostic Parameters to Identify Aggressive Penile Carcinomas (2023) Mink JN, Khalmurzaev O, Pryalukhin A, Geppert CI, Lohse S, Bende K, Lobo J, et al. Journal article Bedeutung von HPV-Status und p16 für die Prognose des Peniskarzinoms (2023) Mink JN, Khalmurzaev O, Pryalukhin A, Hölters S, Geppert CI, Lohse S, Bende K, et al. Journal article The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer (2022) Mohr T, Zwick A, Hans MC, Bley IA, Braun FL, Khalmurzaev O, Matveev VB, et al. Journal article IDKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells (2022) Bley IA, Zwick A, Hans MC, Thieser K, Wagner V, Ludwig N, Khalmurzaev O, et al. Journal article, Review article miRNA expression characterizes histological subtypes and metastasis in penile squamous cell carcinoma (2021) Hiresh A, Heinzelmann J, Hoelters S, Khalmurzaev O, Pryalukhin A, Loertzer P, Heinzelbecker J, et al. Conference contribution Mirna expression characterizes histological subtypes and metastasis in penile squamous cell carcinoma (2021) Ayoubian H, Heinzelmann J, Hölters S, Khalmurzaev O, Pryalukhin A, Loertzer P, Heinzelbecker J, et al. Journal article Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. (2021) Bottomley A, Coens C, Mierzynska J, Blank CU, Mandalà M, Long GV, Atkinson VG, et al. Journal article Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. (2021) Eggermont AM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, et al. Journal article Challenging the prognostic impact of the new WHO and TNM classifications with special emphasis on HPV status in penile carcinoma (2019) Hölters S, Khalmurzaev O, Pryalukhin A, Loertzer P, Janssen M, Heinzelbecker J, Ueberdiek S, et al. Journal article Quality assurance guidelines for interstitial hyperthermia (2019) Trefna HD, Schmidt M, Van Rhoon GC, Kok HP, Gordeyev SS, Lamprecht U, Marder D, et al. Journal article